Transducer of erbB2.1 (TOB1) is a member of the B-cell translocation gene (BTG)/transducer of erbB2 (TOB) anti‑proliferative protein family. Previous studies have demonstrated that overexpression of TOB1 significantly enhances the radiosensitivity of breast and cervical cancer cells. However, the potential mechanisms of TOB1 are still debated. In the present study, we evaluated the effects of infrared (IR) radiation on TOB1 expression in the human lung cancer cell lines NCI-H1975 and A549 via western blot analysis. NCI-H1975 cells were transfected with TOB1 recombinant plasmid, and A549 cells were treated with TOB1-small interfering RNA (siRNA) to establish gain-of-function and loss-of‑function cell models. The effects of radiation and TOB1 overexpression and silencing on clonogenic survival, cell cycle distribution and DNA repair were assessed. Western blot analysis was performed to determine the related mechanisms. The expression levels of TOB1 were significantly induced by IR radiation. Overexpression of TOB1 abrogated radiation-induced G2/M arrest, reduced clonogenic cell survival and enhanced γ-H2AX foci in NCI-H1975 cells exposed to irradiation. TOB1-siRNA demonstrated opposite effects in A549 cells. TOB1 regulated the activation of mitogen-activated protein kinase (MAPK) and modulated the phosphorylation of p53 via activation of the MAPK/extracellular signal-regulated kinase (ERK) pathway. The findings suggest that TOB1 may be a novel molecular target of irradiation. TOB1 modulated the radiosensitivity of lung cancer cells via the MAPK/ERK signaling pathway.

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2013.2403DOI Listing

Publication Analysis

Top Keywords

tob1
12
transducer erbb21
8
erbb21 tob1
8
overexpression tob1
8
cancer cells
8
radiation tob1
8
lung cancer
8
western blot
8
blot analysis
8
nci-h1975 cells
8

Similar Publications

Nanographene oxide (nGO) nanoparticles (NPs) have unique properties and are widely used in various fields, including biomedicine. These NPs, however, also exhibit toxic ef-fects and therefore, the understanding of the molecular mechanism of nGO toxicity is very im-portant mainly for the nanomedicine, especially the cancer therapy. This study aimed to examine the impact of nGO NPs on the expression of genes associated with endoplasmic reticulum (ER) stress, proliferation, and cancerogenesis in both normal human astrocytes and U87MG glioblas-toma cells.

View Article and Find Full Text PDF

[The discovery of JAL-TA9 which cleaves amyloid-β with proteolytic activity].

Nihon Yakurigaku Zasshi

November 2024

Department of Pharmacology, Kochi Medical School, Kochi University.

Amyloid-β (Aβ) 42, one of the causes of Alzheimer's disease (AD), is produced by the cleavage of amyloid precursor protein (APP) by β- or γ-secretases. Since Aβ42 oligomers exhibit strong neurotoxicity, Aβ42 is predicted to be a potentially efficient target for drug therapies. Recently, we screened peptides that activate MMP7 using our peptide library and found that the synthetic peptide JAL-TA9 (YKGSGFRMI), which is derived from the BoxA region of Tob1 protein, showed proteolytic activity.

View Article and Find Full Text PDF

Gastric cancer is one of the most malignant digestive tract tumors worldwide and its progression is associated with gene expression and metabolic alteration. We revealed that the gastric cancer patients with lower expression level of TOB1 exhibited poorer overall survivals according to the data in Kaplan-Meier Plotter. The unphosphorylated TOB1 protein which is effective expressed lower in gastric cancer cells.

View Article and Find Full Text PDF

HYENA detects oncogenes activated by distal enhancers in cancer.

Nucleic Acids Res

September 2024

Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA.

Article Synopsis
  • Somatic structural variations in cancer can disrupt the genome, leading to enhancer hijacking that activates proto-oncogenes, but most research has focused on protein-coding genes.
  • A new computational algorithm called 'HYENA' is designed to identify both protein-coding and non-coding oncogenes influenced by enhancer hijacking by analyzing tumor genome and transcriptome data.
  • In studying 1146 tumors across 25 types, the researchers found 108 candidate oncogenes, including the long non-coding RNA TOB1-AS1, which promotes metastasis in pancreatic cancer cases.
View Article and Find Full Text PDF

Loss of Tob1 promotes muscle regeneration through muscle stem cell expansion.

J Cell Sci

August 2024

Department of Muscle Development and Regeneration, Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Kumamoto, 860-0811, Japan.

Muscle stem cells (MuSCs) play an indispensable role in postnatal muscle growth and hypertrophy in adults. MuSCs also retain a highly regenerative capacity and are therefore considered a promising stem cell source for regenerative therapy for muscle diseases. In this study, we identify tumor-suppressor protein Tob1 as a Pax7 target protein that negatively controls the population expansion of MuSCs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!